Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Di Mario F is active.

Publication


Featured researches published by Di Mario F.


Nephron | 1989

Renal Tubular Dysfunction in Pancreatic Cancer and Chronic Pancreatitis

Fabris C; Daniela Basso; Del Favero G; Piccoli A; Angonese C; Di Mario F; Plebani M; Bonvicini P; Burlina A; R. Naccarato

Urinary excretion of alpha-glucosidase (AGL), gamma-glutamyltransferase (GGT) and ribonuclease (RNase), and serum amylase and immunoreactive trypsin (IRT) were determined in 38 control subjects, 48 patients with pancreatic cancer, 77 with chronic pancreatitis and 47 with extrapancreatic diseases in order to ascertain the presence of a renal tubular damage and to investigate its etiology. A significantly increased frequency of pathological results for all urinary enzymes was documented in the various groups of patients as compared to controls. Significant correlations were detected among AGL, GGT and RNase. Considering the subjects as a whole, GGT and RNase excretions correlated with serum IRT and amylase; the two urinary enzymes were found to be higher when jaundice was present. In chronic pancreatic disease enzymuria was related to increased serum pancreatic enzymes; in extrapancreatic diseases it was associated to hyperbilirubinemia. The vast majority of patients with pancreatic cancer and elevated urinary enzymes presented hepatic metastases and/or jaundice. We can conclude that an anatomical and functional tubular impairment is detectable in some patients with chronic pancreatic and extrapancreatic diseases. Tubular damage seems to least in part to be related to pancreatic inflammation and necrosis in chronic pancreatic disease, while jaundice may be found to play an important role in diseases of the hepatobiliary tract. In pancreatic cancer, liver dysfunction (presence of liver metastases and/or extrahepatic cholestasis) also appears to be involved in altering tubular cells.


The Canadian Journal of Psychiatry | 1987

Personality patterns and duodenal ulcer relapse under antisecretory treatment

Magni G; Di Mario F; Conlon P; Naccarato R

The personality pattern of duodenal ulcer (DU) patients on maintenance treatment who relapsed (N = 22) was compared to a similar group who did not relapse (N = 57) using the Sixteen Personality Factors Questionnaire Multivariate analysis of data indicated that a subgroup of DU patients with personality marked by dependent and anxiety traits was more prone to relapse of illness.


The Italian journal of gastroenterology | 1992

What do patients want to know about their inflammatory bowel disease

Martin A; Leone L; Castagliuolo I; Di Mario F; R. Naccarato


The American Journal of Gastroenterology | 1996

Azithromycin for the cure of Helicobacter pylori infection

Di Mario F; Dal Bò N; Grassi Sa; Massimo Rugge; Cassaro M; Donisi Pm; Vianello F; Kusstatscher S; Salandin S; Grasso Ga; Ferrana M; G. Battaglia


The Italian journal of gastroenterology | 1991

Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?

Fabio Farinati; Di Mario F; Mario Plebani; Cielo R; Fanton Mc; Valiante F; Masiero M; De Boni M; Della Libera G; Burlina A


The Italian journal of gastroenterology | 1994

High IgE serum levels and peptic ulcers : clinical and functional approach

De Lazzari F; Mancin O; Mario Plebani; Venturi C; G. Battaglia; Vianello F; Galliani Ea; Di Mario F; R. Naccarato


Acta bio-medica : Atenei Parmensis | 2002

Lactoferrin: mechanism of action, clinical significance and therapeutic relevance.

Giulia Martina Cavestro; Ingegnoli Av; Aragona G; Iori; Mantovani N; Altavilla N; Dal Bò N; Pilotto A; Bertelè A; Franzè A; Di Mario F; Borghi L


The Italian journal of gastroenterology | 1991

Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study

Massimo Rugge; Baffa R; Fabio Farinati; Di Mario F; Guido M; Valiante F; Ninfo


European Review for Medical and Pharmacological Sciences | 2013

Intermittent versus every-day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study.

Tursi A; Di Mario F; Brandimarte G; Elisei W; Picchio M; Loperfido S; Dal Bò N; Ferrara F; Marcello R; Heras Salvat H; Scarpignato C


Clinical Therapeutics | 1994

The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly.

Pilotto A; Di Mario F; G. Battaglia; Vigneri S; Leandro G; Franceschi M; De Boni M; Grasso A; Vianello F; R. Naccarato

Collaboration


Dive into the Di Mario F's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge